Integrated BioPharma, Inc. (INBP)

Integrated BioPharma Income Statement

Financials in millions USD. Fiscal year is July - June.

Year	2023	2022	2021	2020	2019
Revenue	50.67	56.25	63.56	52.77	49.98
Revenue Growth (YoY)	-9.91%	-11.51%	20.45%	5.59%	14.34%
Cost of Revenue	46.61	49.69	54.08	46.04	43.76
Gross Profit	4.06	6.55	9.48	6.73	6.22
Selling, General & Admin	3.94	3.81	3.7	3.47	3.52
Other Operating Expenses	0.04	-0.09	0.06	-0.27	-0.02
Operating Expenses	3.94	3.81	3.7	3.47	3.52
Operating Income	0.12	1.97	5.78	2.38	2.7
Interest Income	0.01	0.13	0.26	0.4	0.63
Interest Expense	0.04	0.11	0.26	0.4	0.63
Other Expense / Income	-0.01	-0.61	-1.46	-0.7	0.66
Pretax Income	0.1	2.6	7.25	3.09	2.04
Income Tax	0.13	-1.24	-0.77	-1.02	0.35
Net Income	-0.03	3.84	8.01	4.11	1.69
Net Income Growth	-	-52.10%	95.06%	143.36%	148.60%
Shares Outstanding (Basic)	30	30	30	30	29
Shares Outstanding (Diluted)	30	32	32	31	30
Shares Change	-7.34%	0.65%	3.07%	5.31%	-2.41%
EPS (Basic)	-0.00	0.13	0.27	0.14	0.06
EPS (Diluted)	-0.00	0.12	0.25	0.13	0.06
EPS Growth	-	-52.00%	92.31%	127.67%	154.91%
Free Cash Flow	1.12	3.61	2.76	1.13	-0.09
Free Cash Flow Per Share	0.04	0.11	0.09	0.04	-0.00
Gross Margin	8.01%	11.65%	14.92%	12.75%	12.45%
Operating Margin	0.24%	3.50%	9.10%	4.52%	5.41%
Profit Margin	-0.07%	6.82%	12.61%	7.78%	3.38%
Free Cash Flow Margin	2.20%	6.41%	4.33%	2.13%	-0.17%
Effective Tax Rate	134.00%	-47.79%	-10.57%	-33.03%	17.34%
EBITDA	1.3	2.8	6.67	3.16	3.46
EBITDA Margin	2.57%	4.98%	10.49%	5.98%	6.92%
Depreciation & Amortization	1.15	0.83	0.83	0.77	0.77
EBIT	0.15	1.97	5.84	2.38	2.69
EBIT Margin	0.29%	3.50%	9.19%	4.52%	5.37%

Sources: The data provider is Financial Modeling Prep and the numbers are sourced from SEC filings.